Business · 22/08/2019Updated: 10/17/2026 · 1 min read
FDA Corrects Notice on Opioid Analgesic Approvals and Incentives for Pain and Addiction Treatment
Summary
The Food and Drug Administration (FDA) is correcting a notice regarding opioid analgesic approvals and incentives for new pain and addiction treatments, which was published with incorrect deadlines in the Federal Register on June 21, 2019.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →